Amniotic membrane promotes doxorubicin potency by suppressing SH-SY5Y neuroblastoma cell angiogenesis
These findings suggest hAME as a promising adjuvant therapy for NB, potentially offering an effective and safe treatment strategy by targeting multiple hallmarks of NB.
Authors
- Shaimaa Shouman
- Radwa Ayman Salah (ORCID: https://orcid.org/0000-0002-6838-5520)
- Alaa E. Hussein (ORCID: https://orcid.org/0000-0003-0949-9947)
- Nagwa El‐Badri (ORCID: https://orcid.org/0000-0002-1965-611X)
- Omaima Idris
- Eman Ashraf (ORCID: https://orcid.org/0000-0003-0928-3580)
- Shireen Magdy (ORCID: https://orcid.org/0000-0003-4365-4541)
- Ola A. Gaser
- Ahmed M. Abou‐Shanab
Institutions
- Cairo University (EG)
- Zewail City of Science and Technology (EG)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1186/s12885-025-14442-z
- Citations
- 4
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.56
Funders
- Academy of Scientific Research and Technology
- Pohang University of Science and Technology
- Science and Technology Development Fund